AnaptysBio, Inc.
Status: Publicly traded
Direct answer
AnaptysBio, Inc. is publicly traded on NASDAQ under the ticker ANAB.
AnaptysBio, Inc. is a biotechnology firm currently in the clinical development phase, dedicated to pioneering novel therapeutic agents aimed at treating inflammatory conditions and immuno-oncological diseases. The company's portfolio features several promising drug candidates. These include Imsidolimab, an antibody designed to block the interleukin-36 receptor (IL-36R), targeting diverse skin-related inflammatory...
Can you invest in AnaptysBio, Inc.?
Yes. AnaptysBio, Inc. is publicly traded on NASDAQ under the ticker ANAB.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for AnaptysBio, Inc.
Detailed equity research is provided by MarketSnap.